No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs138697490 |
chr18:44337760-44337761 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs370603825 |
chr18:44337794-44337795 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs571992375 |
chr18:44337805-44337806 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs540954538 |
chr18:44337823-44337824 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs561331064 |
chr18:44337833-44337834 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs538044304 |
chr18:44337837-44337838 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs72903352 |
chr18:44337870-44337871 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs550205447 |
chr18:44337879-44337880 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs563631334 |
chr18:44337939-44337940 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs183471803 |
chr18:44337949-44337950 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs552817701 |
chr18:44337957-44337958 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs566307466 |
chr18:44337984-44337985 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs535333950 |
chr18:44337992-44337993 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs548943649 |
chr18:44338008-44338009 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs567215164 |
chr18:44338009-44338010 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs535874381 |
chr18:44338070-44338071 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs556196009 |
chr18:44338071-44338072 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs3809961 |
chr18:44338072-44338073 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
19 |
rs538381956 |
chr18:44338158-44338159 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs73434973 |
chr18:44338209-44338210 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs377645169 |
chr18:44338223-44338224 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs3809962 |
chr18:44338245-44338246 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
23 |
rs540917900 |
chr18:44338285-44338286 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs561034738 |
chr18:44338393-44338394 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs73953884 |
chr18:44338394-44338395 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs553775946 |
chr18:44338429-44338430 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs11661172 |
chr18:44338430-44338431 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs371355571 |
chr18:44338434-44338435 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs557777248 |
chr18:44338546-44338547 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs577745662 |
chr18:44338547-44338548 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs532632454 |
chr18:44338613-44338614 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs546368252 |
chr18:44338615-44338616 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs577450008 |
chr18:44338691-44338692 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs190415909 |
chr18:44338710-44338711 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs75017403 |
chr18:44338747-44338748 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs78742175 |
chr18:44338750-44338751 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs75225570 |
chr18:44338751-44338752 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs80338448 |
chr18:44338754-44338755 |
Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs35271871 |
chr18:44338868-44338869 |
Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs542060562 |
chr18:44338895-44338896 |
Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs372258670 |
chr18:44338899-44338900 |
Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs9965325 |
chr18:44338936-44338937 |
Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs182349156 |
chr18:44338955-44338956 |
Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs529659472 |
chr18:44339314-44339315 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs185342544 |
chr18:44339425-44339426 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs115494959 |
chr18:44339561-44339562 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs115496111 |
chr18:44339583-44339584 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs538342996 |
chr18:44339594-44339595 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs558271035 |
chr18:44339644-44339645 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|